EARLY STAGE MEDTECH:
Address U.S. reimbursement challenges confidently.
Hit your milestones. Land your next round.
COUSTIER ADVISORY CAN HELP.
We help medtech innovators achieve widespread reimbursement coverage in the U.S.
What are your current challenges?
Securing funding by confidently addressing investor questions about reimbursement
Confirming your value proposition and business model with hospital administrators
Figuring out how to avoid expensive post-approval reimbursement clinical studies
Validating coding to ensure optimal claims processing and payment
Coustier Advisory has supported medtech innovations in their earliest stages to achieve widespread reimbursement coverage in the U.S., paving the way to acquisition or IPO.
Your Questions | Our Services
EARLY-STAGE
-
Can we validate our business model with U.S. healthcare stakeholders?
-
We want to use an existing code, but the payment rate is way too low. What are our options?
-
Would payers be able to make decisions with device performance data, or do they need something else?
-
What are the strategic considerations of pursuing
clinical trial reimbursement?
REIMBURSEMENT ASSESSMENTS
U.S. STAKEHOLDER INTERVIEWS
EVIDENCE STRATEGIES
COMMERCIALIZING
-
Do we go after payer coverage aggressively? How
would we get in front of health plans? -
Would we qualify for NTAP or Transitional Pass-Through?
-
How early do we need to start talking to specialty
societies to get our own CPT code, and how can we
influence the payment rate? -
What do customers need in
order to pitch our tech to Value Access Committees?
CODING & PAYMENT APPLICATIONS
PAYER ENGAGEMENT
REIMBURSEMENT SUPPORT LINES
BROADER MARKET ACCESS
-
When can we convert our tracking code to a permanent code with national payment?
-
How do we protect our favorable payment with competitors on our heels?
-
What can our sales teams say about reimbursement?
-
We heard running programs for customers might run afoul of some anti-kickback regulations. What is the real risk?
PAYMENT POLICY ADVOCACY
PATIENT ACCESS PROGRAM DESIGN
CUSTOMER, FIELD TEAM TOOLS
"We were clueless about the U.S. reimbursement pathway, what it takes to commercialise the product. Working with Coustier Advisory, we understood how the reimbursement pathway needed to be integrated with regulatory, and more importantly, the steps and costs associated with it to realise our target." - S. Kathamachu
.jpg)
NICOLE COUSTIER
Nicole Coustier, founder of Coustier Advisory, is a veteran medtech startup advisor who has spent 20+ years helping the life sciences industry launch innovative medical technologies successfully in the U.S.
​She has worked with hospitals and physicians, specialty societies and government agencies, public and private insurance health plans, sales & marketing teams and legal compliance experts, to align incentives to embrace and scale medical technology innovation in healthcare.
OTHER WAYS TO CONNECT
V I S I O N
All stakeholders in the U.S. healthcare system work in partnership to improve patient outcomes.
M I S S I O N
Educate medtech on stakeholder requirements, then facilitate ways to meet those requirements.
V A L U E S
Accuracy. Transparency.
Simplicity. Reliability.